172 related articles for article (PubMed ID: 38282150)
21. Identification of m6A-related lncRNAs for thyroid cancer recurrence.
Wang X; Su D; Wei Y; Liu S; Gao S; Tian H; Wei W
Gland Surg; 2023 Jan; 12(1):39-53. PubMed ID: 36761480
[TBL] [Abstract][Full Text] [Related]
22. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
Front Genet; 2021; 12():744304. PubMed ID: 34976004
[TBL] [Abstract][Full Text] [Related]
23. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
[TBL] [Abstract][Full Text] [Related]
24. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J
Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203
[No Abstract] [Full Text] [Related]
25. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
Liu Y; Yin Z; Wang Y; Chen H
Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma.
Wang K; Yu M; Zhang Z; Yin R; Chen Q; Zhao X; Yu H
Transl Cancer Res; 2023 May; 12(5):1270-1289. PubMed ID: 37304554
[TBL] [Abstract][Full Text] [Related]
27. Investigating the clinical role and prognostic value of genes related to insulin-like growth factor signaling pathway in thyroid cancer.
Liu J; Miao X; Yao J; Wan Z; Yang X; Tian W
Aging (Albany NY); 2024 Feb; 16(3):2934-2952. PubMed ID: 38329437
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencing.
Zhang J; Wang H; Tian Y; Li T; Zhang W; Ma L; Chen X; Wei Y
Lipids Health Dis; 2023 Dec; 22(1):212. PubMed ID: 38042786
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
[TBL] [Abstract][Full Text] [Related]
30. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
31. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
32. Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules.
Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14817-14831. PubMed ID: 37596371
[TBL] [Abstract][Full Text] [Related]
33. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Prognostic 3-Gene Risk Prediction Model for Thyroid Cancer.
Zhao H; Zhang S; Shao S; Fang H
Front Endocrinol (Lausanne); 2020; 11():510. PubMed ID: 32849296
[No Abstract] [Full Text] [Related]
35. Stem cell index-based RiskScore model for predicting prognosis in thyroid cancer and experimental verification.
Chen R; Gao W; Liang L; Yu H; Song W
Heliyon; 2024 Jun; 10(11):e31970. PubMed ID: 38868069
[TBL] [Abstract][Full Text] [Related]
36. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on NK cell marker genes to predict prognosis and immunotherapy response in hepatocellular carcinoma.
Yang D; Zhao F; Su Y; Zhou Y; Shen J; Yu B; Zhao K; Ding Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10609-10621. PubMed ID: 37296316
[TBL] [Abstract][Full Text] [Related]
37. A Novel Prognostic Signature of comprising Nine NK Cell signatures Based on Both Bulk RNA Sequencing and Single-Cell RNA Sequencing for Hepatocellular Carcinoma.
Yu Q; Shi X; Wang H; Zhang S; Hu S; Cai T
J Cancer; 2023; 14(12):2209-2223. PubMed ID: 37576389
[No Abstract] [Full Text] [Related]
38. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.
Zhou Y; Guo Y; Wang Y
IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485
[TBL] [Abstract][Full Text] [Related]
39. Expression of pyroptosis-associated genes and construction of prognostic model for thyroid cancer.
Guo L; Yuan M; Jiang S; Jin G; Li P
Transl Cancer Res; 2023 Dec; 12(12):3360-3383. PubMed ID: 38193001
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]